
Valneva announces HSR clearance for Lyme vaccine collaboration with Pfizer
Saint-Herblain (France), June 8 2020 – Valneva SE (“Valneva” or “the Company”) announced today that the antitrust-related condition precedent for its Lyme vaccine collaboration agreement (the “Agreement”) with Pfizer (NYSE: PFE) has been met. As a result, …